Sangamo BioSciences | SGMO - أصول متداولة





أصول متداولة تغيير تاريخ
Alaunos Therapeutics USD 970K 1.02M 2026-03
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 34.96B 3.49B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Grifols EUR 5.96B 316.31M 2025-12
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 41.36B 1.46B 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06